ATH 11.1% 0.4¢ alterity therapeutics limited

Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress, page-29

  1. 44 Posts.
    lightbulb Created with Sketch. 12
    I would wager that there were people buying in on Thursday and Friday (Australian time) just before the AAN conference is slated to commence. The significant increase in volume observed would seem to confirm this.

    At the very least, some people could be buying the story and spectulating that it is true. In 2014 when the market was awaiting the PTB2 results, the share price increased from A$0.16 to A$1.24, a 675% increase. The 675% return for ATH would be the lower end of what I would personally estimate to be the potential returns in the next year or so.

    If ATH follows a similar upward trajectory as NEU (2008-2022, then this could be the start of the upward long term swing towards a AUD$1 share price.


 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $1.528K 317.5K

Buyers (Bids)

No. Vol. Price($)
102 97511267 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179254 15
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.